Clinigence Holdings stock analysis
Want to see NUTX full AI Analyst Report?
Clinigence Holdings (NUTX) Stock Price & Analysis
NUTX Stock Chart & Stats
- Day’s Range
- $166.08 - $178.20
- 52-Week Range
- $83.99 - $226.16
- Previous Close
- $173.67
- Volume
- N/A
- Average Volume (3M)
- 138.81K
- Market Cap
- $1.16B
- Enterprise Value
- $1.71B
- Total Cash (Recent Filing)
- $249.91M
- Total Debt (Recent Filing)
- $364.98M
- Price to Earnings (P/E)
- 7.1
- Beta
- 1.83
- Next Earnings
- Mar 04, 2027 (Est.)
- EPS Estimate
- 5.87
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Strong Cash Generation
Operating and free cash flow closely track reported earnings, indicating strong earnings quality and internal funding capacity. This supports hospital expansion, technology investment, and resilience over the next several quarters, although sustaining this strength depends on reversing the recent cash-flow decline.
Hospital Volume And Expansion
Rising hospital visits and a visible development pipeline provide a structural path to expanding capacity and future revenue. Same-hospital growth alongside new openings suggests operating momentum is not dependent solely on acquisitions, while the planned hospital cadence can broaden the platform over time.
Improved Balance Sheet
materially lower leverage improves financial flexibility and reduces the burden carried by future operations compared with earlier periods. A stronger equity base should help support development spending and provide greater capacity to manage reimbursement or earnings volatility through the next several quarters.
Bears Say
Revenue And EBITDA Contraction
The decline in revenue and adjusted EBITDA shows that strong visit growth has not yet translated into sustained financial expansion. Continued contraction could pressure margins, reduce funding available for new facilities, and challenge the durability of the company’s currently strong profitability profile.
Reimbursement Uncertainty
Reimbursement outcomes remain exposed to regulatory change and inconsistent payer execution. Because the company relies substantially on the IDR process for billable visits, adverse legislation or weaker enforcement could reduce payment certainty, extend collections, and pressure revenue realization over time.
Cybersecurity Exposure
The disclosed data-security incident creates an ongoing operational, legal, and reputational exposure while the company determines what information was accessed. Potential patient, employee, provider, and business data involvement could increase remediation and notification obligations even though no material operating impact was identified so far.
Clinigence Holdings News
NUTX FAQ
What was Clinigence Holdings’s price range in the past 12 months?
What is Clinigence Holdings’s market cap?
When is Clinigence Holdings’s upcoming earnings report date?
How were Clinigence Holdings’s earnings last quarter?
Is Clinigence Holdings overvalued?
Does Clinigence Holdings pay dividends?
What is Clinigence Holdings’s EPS estimate?
How many shares outstanding does Clinigence Holdings have?
What happened to Clinigence Holdings’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Clinigence Holdings?
What is the TipRanks Smart Score and how is it calculated?
Clinigence Holdings Stock Smart Score
Company Description
Clinigence Holdings
Nutex Health, Inc. functions as a technology-powered enterprise delivering healthcare services, structured into two key segments: its Hospital division and its Population Health Management division. The Hospital division is tasked with developing and overseeing various healthcare models, encompassing micro-hospitals, specialized medical centers, and hospital outpatient facilities. This segment currently owns and operates 21 locations spanning eight different states. Meanwhile, the Population Health Management division establishes and manages provider networks, such as independent physician associations. Additionally, its management services organizations furnish administrative, operational, and support assistance to its associated hospitals and physician groups. A proprietary, cloud-based technology platform within this division is crucial; it aggregates patient and provider data from multiple information systems, settings, and sources to construct a holistic view, thereby enabling more effective care delivery. The company maintains its corporate headquarters in Houston, Texas.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Thomas T. Vo
- Employees
- 1,037
- Website
- www.nutexhealth.com
- Address
- 1776 Yorktown Street, Houston, TX, 77056, US
Clinigence Holdings (NUTX) Earnings & Revenues
NUTX Earnings Call
Earnings Call SentimentPositive
The call was broadly positive, supported by strong hospital visit growth, higher net income, substantial cash generation, a growing development pipeline, favorable IDR litigation outcomes and continued investment in operations and technology. However, the company reported significant year-over-year declines in revenue and adjusted EBITDA, lower third-quarter profitability metrics, higher expense ratios, slightly weaker physician collections and ongoing reimbursement and legislative uncertainty. Overall, the positive operational, cash flow and strategic developments outweighed the stated financial and regulatory challenges.
View all NUTX earnings summariesNUTX Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 3 | 12 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 2 | 0 | 10 |












